1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Therapeutic efficacy by symptom scores and cosmetic scores, before and after the procedurea
No Initial Score Last Score Symptom Cosmetic Symptom Cosmetic 1 5 4 1 1 2 3 4 2 3 3 3 4 0 1 4 3 4 1 3 5 4 3 0 1 6 5 4 0 1 7 3 4 3 2 8 5 4 0 1 9 5 4 0 1 10 5 4 0 1 11 3 4 1 1 Mean 4.0 ± 1.0 3.9 ± 0.3 0.7 ± 1.0 1.5 ± 0.8
a Patients rated symptom scores on a visual analog scale of 0–10. Physicians evaluated the cosmetic grade as grade 1, no palpable mass; grade 2, invisible but palpable mass; grade 3, mass visible only to an experienced clinician; and grade 4, easily visible mass. Initial status versus last examination of symptom scores (P = .005). Initial status versus last examination of cosmetic grades (P = .003).